Here’s where to find the winners as artificial intelligence transitions from an emerging technology to an adolescent one.

Fintel reports that on July 11, 2025, Raymond James initiated coverage of Janux Therapeutics (NasdaqGM:JANX) with a Outperform recommendation. Analyst Price Forecast Suggests 238.97% Upside As of June ...